SG11201504201RA - Purification of x-ray contrast agents - Google Patents
Purification of x-ray contrast agentsInfo
- Publication number
- SG11201504201RA SG11201504201RA SG11201504201RA SG11201504201RA SG11201504201RA SG 11201504201R A SG11201504201R A SG 11201504201RA SG 11201504201R A SG11201504201R A SG 11201504201RA SG 11201504201R A SG11201504201R A SG 11201504201RA SG 11201504201R A SG11201504201R A SG 11201504201RA
- Authority
- SG
- Singapore
- Prior art keywords
- purification
- contrast agents
- ray contrast
- ray
- agents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/22—Separation; Purification; Stabilisation; Use of additives
- C07C231/24—Separation; Purification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/46—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having carbon atoms of carboxamide groups, amino groups and at least three atoms of bromine or iodine, bound to carbon atoms of the same non-condensed six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12198020 | 2012-12-19 | ||
| PCT/US2013/070699 WO2014099214A1 (en) | 2012-12-19 | 2013-11-19 | Purification of x-ray contrast agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201504201RA true SG11201504201RA (en) | 2015-07-30 |
Family
ID=47458704
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201504201RA SG11201504201RA (en) | 2012-12-19 | 2013-11-19 | Purification of x-ray contrast agents |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9938233B2 (en) |
| EP (1) | EP2935204B1 (en) |
| JP (2) | JP6342421B2 (en) |
| KR (1) | KR102180250B1 (en) |
| CN (1) | CN104854080B (en) |
| AU (1) | AU2013364113B2 (en) |
| CA (1) | CA2890449C (en) |
| ES (1) | ES2690128T3 (en) |
| HU (1) | HUE039458T2 (en) |
| IN (1) | IN2015DN03980A (en) |
| NZ (1) | NZ708503A (en) |
| PL (1) | PL2935204T3 (en) |
| RU (1) | RU2662941C2 (en) |
| SG (1) | SG11201504201RA (en) |
| WO (1) | WO2014099214A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013364113B2 (en) | 2012-12-19 | 2018-01-18 | Ge Healthcare As | Purification of X-ray contrast agents |
| KR101699539B1 (en) * | 2015-12-30 | 2017-02-13 | (주)솔레이어 | Nano filteration module and condensation method using the same |
| CN113121377A (en) * | 2019-12-31 | 2021-07-16 | 江苏汉邦科技有限公司 | Purification method of iodixanol |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5447635A (en) * | 1991-02-26 | 1995-09-05 | Bracco International B.V. | Process of concentration and purification of organic compounds |
| IT1248741B (en) | 1991-02-26 | 1995-01-26 | Bracco Spa | CONCENTRATION AND PURIFICATION PROCESS OF ORGANIC COMPOUNDS |
| US5221485A (en) * | 1991-12-03 | 1993-06-22 | Mallinckrodt Medical, Inc. | Purification of X-ray contrast agent, magnetic resonance imaging agent, or radiopharmaceuticals using reverse osmosis |
| EP0612692B1 (en) | 1993-02-26 | 1999-01-20 | Createrra Inc. | Method for production of water purifying substances |
| IL110391A (en) * | 1993-07-30 | 1998-12-06 | Zambon Spa | Process for the crystallization of iopamidol |
| US5811581A (en) | 1994-08-04 | 1998-09-22 | Dibra S.P.A. | Process for the purification of opacifying contrast agents |
| IT1282674B1 (en) | 1996-02-23 | 1998-03-31 | Bracco Spa | PROCESS FOR THE PURIFICATION OF MATTING CONTRASTING AGENTS |
| US6425885B1 (en) | 1999-12-20 | 2002-07-30 | Ultradent Products, Inc. | Hydraulic syringe |
| NO20043305D0 (en) | 2004-08-09 | 2004-08-09 | Amersham Health As | Preparation of lodixanol |
| NO20053676D0 (en) | 2005-07-29 | 2005-07-29 | Amersham Health As | Crystallization Process |
| NO20055643D0 (en) | 2005-11-29 | 2005-11-29 | Amersham Health As | Preparation of lodixanol |
| CN103980154B (en) * | 2007-07-12 | 2015-02-25 | 通用电气医疗集团股份有限公司 | Contrast agents |
| JP2011509943A (en) | 2008-01-14 | 2011-03-31 | マリンクロッド・インコーポレイテッド | Process for preparing iosimenol |
| US20110021823A1 (en) * | 2009-07-21 | 2011-01-27 | Ge Healthcare As | Processing crude iodixanol mixture by nanofiltration |
| JP5775524B2 (en) * | 2009-11-26 | 2015-09-09 | アイマックス ダイアグノスティック イメージング ホールディング リミテッド | Preparation and purification of iodixanol |
| CN103347850B (en) | 2010-12-21 | 2016-01-20 | 通用电气医疗集团股份有限公司 | Comprise the desalination of the composition of contrast medium |
| AU2013364113B2 (en) | 2012-12-19 | 2018-01-18 | Ge Healthcare As | Purification of X-ray contrast agents |
-
2013
- 2013-11-19 AU AU2013364113A patent/AU2013364113B2/en active Active
- 2013-11-19 NZ NZ708503A patent/NZ708503A/en unknown
- 2013-11-19 KR KR1020157015950A patent/KR102180250B1/en active IP Right Grant
- 2013-11-19 CN CN201380066485.8A patent/CN104854080B/en active Active
- 2013-11-19 EP EP13864437.2A patent/EP2935204B1/en active Active
- 2013-11-19 WO PCT/US2013/070699 patent/WO2014099214A1/en active Application Filing
- 2013-11-19 IN IN3980DEN2015 patent/IN2015DN03980A/en unknown
- 2013-11-19 SG SG11201504201RA patent/SG11201504201RA/en unknown
- 2013-11-19 US US14/442,203 patent/US9938233B2/en active Active
- 2013-11-19 PL PL13864437T patent/PL2935204T3/en unknown
- 2013-11-19 HU HUE13864437A patent/HUE039458T2/en unknown
- 2013-11-19 RU RU2015121502A patent/RU2662941C2/en active
- 2013-11-19 ES ES13864437.2T patent/ES2690128T3/en active Active
- 2013-11-19 CA CA2890449A patent/CA2890449C/en active Active
- 2013-11-19 JP JP2015549398A patent/JP6342421B2/en active Active
-
2018
- 2018-03-26 JP JP2018057348A patent/JP2018115193A/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US20160304440A1 (en) | 2016-10-20 |
| NZ708503A (en) | 2019-08-30 |
| EP2935204B1 (en) | 2018-09-05 |
| EP2935204A1 (en) | 2015-10-28 |
| KR102180250B1 (en) | 2020-11-18 |
| PL2935204T3 (en) | 2018-12-31 |
| CA2890449C (en) | 2020-12-29 |
| CN104854080B (en) | 2018-07-03 |
| US9938233B2 (en) | 2018-04-10 |
| JP2018115193A (en) | 2018-07-26 |
| AU2013364113A1 (en) | 2015-05-28 |
| KR20150094639A (en) | 2015-08-19 |
| AU2013364113B2 (en) | 2018-01-18 |
| RU2015121502A (en) | 2017-01-26 |
| JP6342421B2 (en) | 2018-06-13 |
| CN104854080A (en) | 2015-08-19 |
| EP2935204A4 (en) | 2016-08-17 |
| JP2016503054A (en) | 2016-02-01 |
| HUE039458T2 (en) | 2019-01-28 |
| CA2890449A1 (en) | 2014-06-26 |
| IN2015DN03980A (en) | 2015-10-02 |
| ES2690128T3 (en) | 2018-11-19 |
| RU2662941C2 (en) | 2018-07-31 |
| WO2014099214A1 (en) | 2014-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2723384A4 (en) | Treatment of proteinopathies | |
| IL287057A (en) | Purification of iduronate-2 sulfatase | |
| EP2826473A4 (en) | Novel use of patchoulol | |
| ZA201406082B (en) | Use of ccr3-inhibitors | |
| SG11201403891SA (en) | Purification of flaviviruses | |
| HK1210718A1 (en) | Antitrichophytosis solution for external use | |
| EP2881113A4 (en) | New application of pogostone | |
| PT2917174T (en) | Preparation of intermediates of x-ray contrast agents | |
| IL232239A0 (en) | Medical use | |
| ZA201308101B (en) | Diagnostic use of prosomatostatin | |
| EP2892529A4 (en) | Uses of (-)-perhexiline | |
| GB201205189D0 (en) | Novel medical use | |
| SG11201504201RA (en) | Purification of x-ray contrast agents | |
| GB201215502D0 (en) | Medical use | |
| FI3473276T3 (en) | Techniques for treatment of abscesses | |
| HK1210421A1 (en) | Use of pregn-4-en-20-yn-3-one for the treatment of depressive disorders -4--20--3- | |
| IL236873A0 (en) | Therapeutic compounds | |
| GB201218263D0 (en) | Treatment of autism | |
| GB201215621D0 (en) | Medical solution | |
| GB201221118D0 (en) | Methods of treatment | |
| GB201216740D0 (en) | Methods of treatment | |
| GB201216748D0 (en) | Methods of treatment | |
| GB201204645D0 (en) | Treatment of disease | |
| GB201212604D0 (en) | New treatment | |
| GB201206325D0 (en) | Methods of treatment |